How does a vaccine get developed, studied, approved, distributed, and administered, and then just … disappear? On Episode 34 of The Politics of Everything, hosts Laura Marsh and Alex Pareene explore what happened to LYMErix, a vaccine for Lyme disease that has been called the only safe and effective vaccine ever to have been voluntarily withdrawn from the market in the United States. What does the story of LYMErix tell us about vaccine hesitancy, liability, and how pharmaceutical companies decide what to sell? And can we expect another Lyme vaccine anytime soon? Guests include Rebecca Onion, who wrote about LYMErix for Slate, and Andrew Zaleski, who wrote about new prophylactic treatments for Lyme for Outside magazine.
Learn more about your ad choices. Visit
megaphone.fm/adchoicesHow does a vaccine get developed, studied, approved, distributed, and administered, and then just … disappear? On Episode 34 of The Politics of Everything, hosts Laura Marsh and Alex Pareene explore what happened to LYMErix, a vaccine for Lyme disease that has been called the only safe and effective vaccine ever to have been voluntarily withdrawn from the market in the United States. What does the story of LYMErix tell us about vaccine hesitancy, liability, and how pharmaceutical companies decide what to sell? And can we expect another Lyme vaccine anytime soon? Guests include Rebecca Onion, who wrote about LYMErix for Slate, and Andrew Zaleski, who wrote about new prophylactic treatments for Lyme for Outside magazine.
Learn more about your ad choices. Visit
megaphone.fm/adchoicesHow does a vaccine get developed, studied, approved, distributed, and administered, and then just … disappear? On Episode 34 of The Politics of Everything, hosts Laura Marsh and Alex Pareene explore what happened to LYMErix, a vaccine for Lyme disease that has been called the only safe and effective vaccine ever to have been voluntarily withdrawn from the market in the United States. What does the story of LYMErix tell us about vaccine hesitancy, liability, and how pharmaceutical companies decide what to sell? And can we expect another Lyme vaccine anytime soon? Guests include Rebecca Onion, who vaccine-history-lymerix-hesitancy-ticks.html">wrote about LYMErix for Slate, and Andrew Zaleski, who wrote about new prophylactic treatments for Lyme for Outside magazine.
Learn more about your ad choices. Visit megaphone.fm/adchoices